Expanded access: opening doors to personalized medicine for rare disease patients and patients with neurodegenerative diseases-Reference-Cited by-同舟云学术

Expanded access: opening doors to personalized medicine for rare disease patients and patients with neurodegenerative diseases

Published:2020-09-05 Issue:5 Volume:288 Page:1457-1461
ISSN:1742-464X
Container-title:The FEBS Journal
language:en
Short-container-title:FEBS J.

Author:

Özdinler P. Hande¹²³⁴^ORCID

Affiliation:

1. Department of Neurology Feinberg School of Medicine Northwestern University Chicago IL USA

2. Chemistry of Life Processes Institute Center for Molecular Innovation and Drug Discovery Center for Developmental Therapeutics Northwestern University Evanston IL USA

3. Mesulam Center for Cognitive Neurology and Alzheimer’s Disease Feinberg School of Medicine Northwestern University Chicago IL USA

4. Les Turner ALS Center at Northwestern UniversityFeinberg School of Medicine Chicago IL USA

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/febs.15529

Reference8 articles.

1. Selective Vulnerability of the Central Nervous System to Hyperbaric Oxygen

2. Cellular ageing: selective vulnerability of cholinergic neurones in human brain;Bowen DM;Monogr Dev Biol,1984

3. Neurological disorders and mitochondria

4. Mitochondrial integrity in neurodegeneration

5. Protein-protein interactions reveal key canonical pathways, upstream regulators, interactome domains, and novel targets in ALS

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Innovation at the Intersection: Emerging Translational Research in Neurology and Psychiatry;Cells;2024-05-07

2. Neurodegenerative Diseases: From Dysproteostasis, Altered Calcium Signalosome to Selective Neuronal Vulnerability to AAV-Mediated Gene Therapy;International Journal of Molecular Sciences;2022-11-16

3. NU-9 improves health of hSOD1G93A mouse upper motor neurons in vitro, especially in combination with riluzole or edaravone;Scientific Reports;2022-03-30

4. Rare disease patients’ needs: an up-to-date analysis and future directions;Pharmacia;2021-10-06

5. Expression of the axon guidance factor Slit2 and its receptor Robo1 in patients with Hirschsprung disease;Medicine;2021-08-20